The NCL has selected our technology Span-based nanoparticles loaded with miR-20a for the preclinical development program
Read MoreNanokide awarded as finalist in the Business Ideas/Projects section of the Toribio Echevarria 2022 awards.
Read MoreNanokide Therapeutics awarded in the category of best R+D+i company in the VI edition of the Cantabrian Excellent Awards.
Read MoreNanokid Therapeutics participated in B-Venture 2022 in Bilbao from 18th to 19th of October
Read More